Antibody Conjugates
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 January 2012) | Viewed by 19752
Special Issue Editor
Interests: antibody; enzyme; drug; prodrug; antibody-enzyme conjugates; antibody-enzyme fusion proteins; immunogenicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issues
- Antibody-Drug Conjugates (ADC): 2021 in Pharmaceuticals (5 articles)
- Multidrug Therapies Containing Monoclonal Antibodies for Multiple Myeloma in Pharmaceuticals (5 articles)
- Monoclonal Antibody in Pharmaceuticals (5 articles)